Individual and Specified Hormones - Medical Devices Pipeline Assessment, 2019
Summary
The Publisher's Medical Devices sector report, “Individual and Specified Hormones - Medical Devices Pipeline Assessment, 2019" provides an overview of Individual and Specified Hormones currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Individual and Specified Hormones pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Reasons to Buy
The report enables you to:
Summary
The Publisher's Medical Devices sector report, “Individual and Specified Hormones - Medical Devices Pipeline Assessment, 2019" provides an overview of Individual and Specified Hormones currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Individual and Specified Hormones pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Individual and Specified Hormones under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Individual and Specified Hormones and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Individual and Specified Hormones under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1.1 List of Tables1.2 List of Figures
2 Introduction
2.1 Individual and Specified Hormones Overview
3 Products under Development
3.1 Individual and Specified Hormones - Pipeline Products by Stage of Development
3.2 Individual and Specified Hormones - Pipeline Products by Segment
3.3 Individual and Specified Hormones - Pipeline Products by Territory
3.4 Individual and Specified Hormones - Pipeline Products by Regulatory Path
3.5 Individual and Specified Hormones - Pipeline Products by Estimated Approval Date
4 Individual and Specified Hormones - Pipeline Products under Development by Companies
4.1 Individual and Specified Hormones Companies - Pipeline Products by Stage of Development
4.2 Individual and Specified Hormones - Pipeline Products by Stage of Development
5 Individual and Specified Hormones Companies and Product Overview
5.1 Alere Inc Company Overview
5.1.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 AMS Diagnostics LLC Company Overview
5.2.1 AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.3 Beckman Coulter Inc Company Overview
5.3.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Carolina Liquid Chemistries Corp Company Overview
5.4.1 Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 Ceres Nanosciences Inc Company Overview
5.5.1 Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Columbia University Company Overview
5.6.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
5.7 DIANA Biotechnologies Company Overview
5.7.1 DIANA Biotechnologies Pipeline Products & Ongoing Clinical Trials Overview
5.8 DiaSorin SpA Company Overview
5.8.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview
5.9 Immunodiagnostic Systems Holdings plc Company Overview
5.9.1 Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Novartis AG Company Overview
5.10.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
5.11 OJ-Bio Ltd (Inactive) Company Overview
5.11.1 OJ-Bio Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.12 Roche Diagnostics International Ltd Company Overview
5.12.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 Sendera Discovery Company Overview
5.13.1 Sendera Discovery Pipeline Products & Ongoing Clinical Trials Overview
5.14 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview
5.14.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 Siemens Healthcare Diagnostics Inc Company Overview
5.15.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Siemens Healthineers AG Company Overview
5.16.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
5.17 Tosoh Bioscience Inc Company Overview
5.17.1 Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Individual and Specified Hormones- Recent Developments
6.1 Nov 04, 2019: Luminex reports third quarter 2019 results and submission of VERIGENE II Gastrointestinal Flex Assay to the FDA
6.2 Oct 16, 2019: Abbott reports third-quarter 2019 results
6.3 Oct 01, 2019: Fortress Diagnostics announces £8m investment in new headquarters
6.4 Sep 12, 2019: Repositioning of Biocrates: Management change and new round of financing
6.5 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership
6.6 Jul 31, 2019: Luminex reports second quarter 2019 financial results and increase in quarterly dividend
6.7 Jul 29, 2019: Siemens Healthineers continues to drive growth forward
6.8 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers
6.9 Jul 17, 2019: Abbott reports second-quarter 2019 results
6.10 Jun 19, 2019: Immunodiagnostic Systems Holdings: Final results for year ended 31 March 2019
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Individual and Specified Hormones - Pipeline Products by Stage of Development
Table 2: Individual and Specified Hormones - Pipeline Products by Segment
Table 3: Individual and Specified Hormones - Pipeline Products by Territory
Table 4: Individual and Specified Hormones - Pipeline Products by Regulatory Path
Table 5: Individual and Specified Hormones - Pipeline Products by Estimated Approval Date
Table 6: Individual and Specified Hormones Companies - Pipeline Products by Stage of Development
Table 7: Individual and Specified Hormones - Pipeline Products by Stage of Development
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Vitamin D Assay - Product Status
Table 10: Vitamin D Assay - Product Description
Table 11: AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 12: LIASYS 330 - Vitamin D Assay - Product Status
Table 13: LIASYS 330 - Vitamin D Assay - Product Description
Table 14: Liasys 450 - Vitamin D Assay - Product Status
Table 15: Liasys 450 - Vitamin D Assay - Product Description
Table 16: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 17: UniCel DxI 860i Synchron Access Clinical System - Vitamin D Assay - Product Status
Table 18: UniCel DxI 860i Synchron Access Clinical System - Vitamin D Assay - Product Description
Table 19: Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 20: CLC 480 Analyzer - Vitamin D Assay - Product Status
Table 21: CLC 480 Analyzer - Vitamin D Assay - Product Description
Table 22: CLC 720i Analyzer - Vitamin D Assay - Product Status
Table 23: CLC 720i Analyzer - Vitamin D Assay - Product Description
Table 24: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Nanotrap Human Growth Hormone Test - Product Status
Table 26: Nanotrap Human Growth Hormone Test - Product Description
Table 27: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Diagnostic Test - Menopause - Product Status
Table 29: Diagnostic Test - Menopause - Product Description
Table 30: DIANA Biotechnologies Pipeline Products & Ongoing Clinical Trials Overview
Table 31: DIANA Assay - Insulin-like Growth Factor Receptor - Product Status
Table 32: DIANA Assay - Insulin-like Growth Factor Receptor - Product Description
Table 33: DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview
Table 34: LIAISON - High Sclerostin Assay - Product Status
Table 35: LIAISON - High Sclerostin Assay - Product Description
Table 36: LIAISON - Hyperphosphate Low Bone Turnover Assay - Product Status
Table 37: LIAISON - Hyperphosphate Low Bone Turnover Assay - Product Description
Table 38: LIAISON XL - Sclerostin Assay - Product Status
Table 39: LIAISON XL - Sclerostin Assay - Product Description
Table 40: Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: IDS-iSYS Cortisol Assay - Product Status
Table 42: IDS-iSYS Cortisol Assay - Product Description
Table 43: IDS-iSYS MGP Assay - Product Status
Table 44: IDS-iSYS MGP Assay - Product Description
Table 45: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Rapid Diagnostic Test - Vitamin D - Product Status
Table 47: Rapid Diagnostic Test - Vitamin D - Product Description
Table 48: OJ-Bio Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Parathyroid Hormone Assay - Product Status
Table 50: Parathyroid Hormone Assay - Product Description
Table 51: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Cobas 6000 Analyzer Series With c 501 Module - IGF BP3 Assay - Product Status
Table 53: Cobas 6000 Analyzer Series With c 501 Module - IGF BP3 Assay - Product Description
Table 54: Cobas 6000 Analyzer Series With c 501 Module - IGF-1 Assay - Product Status
Table 55: Cobas 6000 Analyzer Series With c 501 Module - IGF-1 Assay - Product Description
Table 56: Cobas 8000 Analyzer Series With c 502 Module - IGF BP3 Assay - Product Status
Table 57: Cobas 8000 Analyzer Series With c 502 Module - IGF BP3 Assay - Product Description
Table 58: Cobas 8000 Analyzer Series With c 502 Module - IGF-1 Assay - Product Status
Table 59: Cobas 8000 Analyzer Series With c 502 Module - IGF-1 Assay - Product Description
Table 60: Cobas 8000 Analyzer Series With c 701 Module - IGF BP3 Assay - Product Status
List of Figures
Figure 1: Individual and Specified Hormones - Pipeline Products by Stage of Development
Figure 2: Individual and Specified Hormones - Pipeline Products by Segment
Figure 3: Individual and Specified Hormones - Pipeline Products by Territory
Figure 4: Individual and Specified Hormones - Pipeline Products by Regulatory Path
Figure 5: Individual and Specified Hormones - Pipeline Products by Estimated Approval Date
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alere Inc
- AMS Diagnostics LLC
- Beckman Coulter Inc
- Carolina Liquid Chemistries Corp
- Ceres Nanosciences Inc
- Columbia University
- DIANA Biotechnologies
- DiaSorin SpA
- Immunodiagnostic Systems Holdings plc
- Novartis AG
- Roche Diagnostics International Ltd
- Sendera Discovery
- Shenzhen Mindray Bio-Medical Electronics Co Ltd
- Siemens Healthcare Diagnostics Inc
- Siemens Healthineers AG
- Tosoh Bioscience Inc
